| dc.contributor.author | Bulur, H | |
| dc.contributor.author | Ozturk, S | |
| dc.contributor.author | Orhan, L | |
| dc.contributor.author | Gulbaran, M | |
| dc.contributor.author | Ersanli, M | |
| dc.contributor.author | Babalik, E | |
| dc.contributor.author | Gurmen, T | |
| dc.date.accessioned | 2021-03-04T12:35:17Z | |
| dc.date.available | 2021-03-04T12:35:17Z | |
| dc.date.issued | 2003 | |
| dc.identifier.citation | Babalik E., Gurmen T., Orhan L., Bulur H., Gulbaran M., Ersanli M., Ozturk S., "Increased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in nondiabetic patients", CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, cilt.58, sa.3, ss.306-312, 2003 | |
| dc.identifier.issn | 1522-1946 | |
| dc.identifier.other | av_78079ac2-a4ae-4b8e-9807-c63523e7ffe2 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/82363 | |
| dc.identifier.uri | https://doi.org/10.1002/ccd.10409 | |
| dc.description.abstract | Insulin is known to stimulate proliferation and migration of vascular smooth muscle cells. As the predominant mechanism of restenosis after stent implantation is neointimal tissue proliferation, one can expect a relationship between hyperinsulinemia and restenosis in these patients. The aim of this study was to determine whether hyperinsulinemia during oral glucose tolerance test is a predictor of the development of restenosis after stent implantation in nondiabetic patients. We prospectively studied 52 nondiabetic patients with effort angina who underwent elective stent implantation for single-vessel coronary artery disease. In order to increase the statistical power of the study, numerous exclusion criteria were applied. All patients were subjected to a 75 g oral glucose tolerance test a day before the stent implantation and underwent follow-up angiography 6 months later. Plasma insulin levels in fasting (6.77 +/- 1.57 vs. 5.36 +/- 1.35 muU/ml; P = 0.005), at 30 min (102.48 +/- 10.6 vs. 47.74 +/- 12.75 muU/ml; P = 0.001), 1 hr after (120.23 +/- 14.1 vs. 63.08 +/- 12.62 mu/ml; P = 0.001), 2 hr after (63.58 +/- 8.64 vs. 34.88 +/- 6.82 mu/ml; P = 0.001), and 3 hr after (25.71 +/- 5.65 vs. 23.02 +/- 4.61 mu/ml; P = 0.04) loading were significantly higher in patients with stent restenosis than in patients without stent restenosis. Insulin area and insulin area/glucose area were also significantly higher in patients with stent restenosis than in patients without (219.5 +/- 23.8 vs. 118.9 +/- 21.8, P = 0.001, and 0.62 +/- 0.09 vs. 0.33 +/- 0.06, P = 0.001, respectively). By multiple logistic regression analysis, insulin area during oral glucose tolerance test was found to be an independent predictor of stent restenosis (OR = 1.12; 95% CI = 1.01-1.25; P = 0.031). In conclusion, nondiabetic patients with hyperinsulinemia during oral glucose tolerance test have a high risk for restenosis after stent implantation, and performing this simple test before intervention may be useful for the prediction of stent restenosis. | |
| dc.language.iso | eng | |
| dc.subject | Kardiyoloji | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | CARDIAC ve CARDIOVASCULAR SİSTEMLER | |
| dc.title | Increased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in nondiabetic patients | |
| dc.type | Makale | |
| dc.relation.journal | CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 58 | |
| dc.identifier.issue | 3 | |
| dc.identifier.startpage | 306 | |
| dc.identifier.endpage | 312 | |
| dc.contributor.firstauthorID | 167769 | |